Advanced materials DuPont is actively launching specialized chromatography media such as AmberChrom SIL for peptide therapeutics, indicating a focus on high-purity purification solutions and potential cross-sell opportunities with biopharma manufacturing and contract development organizations.

Healthcare growth Strength in healthcare markets alongside water, construction, and transformation suggests multi-industry demand for specialty chemicals and performance materials, presenting upsell paths into pharma, biotech, and infrastructure segments.

Financial momentum Regular dividend announcements and rising earnings guidance amid ongoing productivity gains and strategic acquisitions signal financial health and capacity for expanded procurement of advanced materials, offering confidence for longer-term procurement contracts.

Strategic investments Notable external investments from institutional buyers and increased stake by funds indicate market confidence in DuPont’s growth trajectory, creating openings for channel partnerships, co-development initiatives, and enhanced distribution channels.

Technology stack Adoption of modern data and workflow tools (Snowflake, Terraform, Power Apps, Apache Airflow) points to digital enablement in operations and customer solutions, suggesting opportunities to offer integration services, data analytics for supply chain optimization, and tailored digital customer experiences.